Matches in SemOpenAlex for { <https://semopenalex.org/work/W3008825137> ?p ?o ?g. }
- W3008825137 endingPage "204" @default.
- W3008825137 startingPage "196" @default.
- W3008825137 abstract "Human pluripotent stem cells (hPSCs) and mesenchymal stromal/stem cells (hMSCs) are clinically relevant sources for cellular therapies and for modeling human development and disease. Many stem cell-based applications rely on the ability to activate several endogenous genes simultaneously to modify cell fate. However, genetic intervention of these cells remains challenging. Several catalytically dead Cas9 (dCas9) proteins fused to distinct activation domains can modulate gene expression when directed to their regulatory regions by a specific single-guide RNA (sgRNA). In this study, we have compared the ability of the first-generation dCas9-VP64 activator and the second-generation systems, dCas9-SAM and dCas9-SunTag, to induce gene expression in hPSCs and hMSCs. Several stem cell lines were tested for single and multiplexed gene activation. When the activation of several genes was compared, all three systems induced specific and potent gene expression in both single and multiplexed settings, but the dCas9-SAM and dCas9-SunTag systems resulted in the highest and most consistent level of gene expression. Simultaneous targeting of the same gene with multiple sgRNAs did not result in additive levels of gene expression in hPSCs nor hMSCs. We demonstrate the robustness and specificity of second-generation dCas9 activators as tools to simultaneously activate several endogenous genes in clinically relevant human stem cells. Human pluripotent stem cells (hPSCs) and mesenchymal stromal/stem cells (hMSCs) are clinically relevant sources for cellular therapies and for modeling human development and disease. Many stem cell-based applications rely on the ability to activate several endogenous genes simultaneously to modify cell fate. However, genetic intervention of these cells remains challenging. Several catalytically dead Cas9 (dCas9) proteins fused to distinct activation domains can modulate gene expression when directed to their regulatory regions by a specific single-guide RNA (sgRNA). In this study, we have compared the ability of the first-generation dCas9-VP64 activator and the second-generation systems, dCas9-SAM and dCas9-SunTag, to induce gene expression in hPSCs and hMSCs. Several stem cell lines were tested for single and multiplexed gene activation. When the activation of several genes was compared, all three systems induced specific and potent gene expression in both single and multiplexed settings, but the dCas9-SAM and dCas9-SunTag systems resulted in the highest and most consistent level of gene expression. Simultaneous targeting of the same gene with multiple sgRNAs did not result in additive levels of gene expression in hPSCs nor hMSCs. We demonstrate the robustness and specificity of second-generation dCas9 activators as tools to simultaneously activate several endogenous genes in clinically relevant human stem cells." @default.
- W3008825137 created "2020-03-06" @default.
- W3008825137 creator A5005617864 @default.
- W3008825137 creator A5024892658 @default.
- W3008825137 creator A5051864161 @default.
- W3008825137 creator A5053494864 @default.
- W3008825137 creator A5053728594 @default.
- W3008825137 creator A5056525976 @default.
- W3008825137 creator A5058583468 @default.
- W3008825137 creator A5066011143 @default.
- W3008825137 creator A5073899064 @default.
- W3008825137 creator A5076464182 @default.
- W3008825137 creator A5079404620 @default.
- W3008825137 creator A5082872325 @default.
- W3008825137 creator A5084169599 @default.
- W3008825137 date "2020-06-01" @default.
- W3008825137 modified "2023-10-08" @default.
- W3008825137 title "Robustness of Catalytically Dead Cas9 Activators in Human Pluripotent and Mesenchymal Stem Cells" @default.
- W3008825137 cites W1930160269 @default.
- W3008825137 cites W2019136342 @default.
- W3008825137 cites W2019670881 @default.
- W3008825137 cites W2020491954 @default.
- W3008825137 cites W2026520402 @default.
- W3008825137 cites W2045435533 @default.
- W3008825137 cites W2061650108 @default.
- W3008825137 cites W2075230442 @default.
- W3008825137 cites W2086943348 @default.
- W3008825137 cites W2101749257 @default.
- W3008825137 cites W2103081715 @default.
- W3008825137 cites W2114484863 @default.
- W3008825137 cites W2127260798 @default.
- W3008825137 cites W2127862779 @default.
- W3008825137 cites W2138977668 @default.
- W3008825137 cites W2159999899 @default.
- W3008825137 cites W2160051211 @default.
- W3008825137 cites W2163173465 @default.
- W3008825137 cites W2166672922 @default.
- W3008825137 cites W2169373177 @default.
- W3008825137 cites W2204875887 @default.
- W3008825137 cites W2208503742 @default.
- W3008825137 cites W2261932813 @default.
- W3008825137 cites W2271701705 @default.
- W3008825137 cites W2400411104 @default.
- W3008825137 cites W2548503078 @default.
- W3008825137 cites W2616184417 @default.
- W3008825137 cites W2737819333 @default.
- W3008825137 cites W2772883664 @default.
- W3008825137 cites W2797959050 @default.
- W3008825137 cites W2972809401 @default.
- W3008825137 doi "https://doi.org/10.1016/j.omtn.2020.02.009" @default.
- W3008825137 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7068053" @default.
- W3008825137 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32171171" @default.
- W3008825137 hasPublicationYear "2020" @default.
- W3008825137 type Work @default.
- W3008825137 sameAs 3008825137 @default.
- W3008825137 citedByCount "9" @default.
- W3008825137 countsByYear W30088251372020 @default.
- W3008825137 countsByYear W30088251372021 @default.
- W3008825137 countsByYear W30088251372022 @default.
- W3008825137 crossrefType "journal-article" @default.
- W3008825137 hasAuthorship W3008825137A5005617864 @default.
- W3008825137 hasAuthorship W3008825137A5024892658 @default.
- W3008825137 hasAuthorship W3008825137A5051864161 @default.
- W3008825137 hasAuthorship W3008825137A5053494864 @default.
- W3008825137 hasAuthorship W3008825137A5053728594 @default.
- W3008825137 hasAuthorship W3008825137A5056525976 @default.
- W3008825137 hasAuthorship W3008825137A5058583468 @default.
- W3008825137 hasAuthorship W3008825137A5066011143 @default.
- W3008825137 hasAuthorship W3008825137A5073899064 @default.
- W3008825137 hasAuthorship W3008825137A5076464182 @default.
- W3008825137 hasAuthorship W3008825137A5079404620 @default.
- W3008825137 hasAuthorship W3008825137A5082872325 @default.
- W3008825137 hasAuthorship W3008825137A5084169599 @default.
- W3008825137 hasBestOaLocation W30088251371 @default.
- W3008825137 hasConcept C104317684 @default.
- W3008825137 hasConcept C107459253 @default.
- W3008825137 hasConcept C132455925 @default.
- W3008825137 hasConcept C145103041 @default.
- W3008825137 hasConcept C150194340 @default.
- W3008825137 hasConcept C165864922 @default.
- W3008825137 hasConcept C16930146 @default.
- W3008825137 hasConcept C198826908 @default.
- W3008825137 hasConcept C28328180 @default.
- W3008825137 hasConcept C502942594 @default.
- W3008825137 hasConcept C54355233 @default.
- W3008825137 hasConcept C86803240 @default.
- W3008825137 hasConcept C95444343 @default.
- W3008825137 hasConcept C98108389 @default.
- W3008825137 hasConceptScore W3008825137C104317684 @default.
- W3008825137 hasConceptScore W3008825137C107459253 @default.
- W3008825137 hasConceptScore W3008825137C132455925 @default.
- W3008825137 hasConceptScore W3008825137C145103041 @default.
- W3008825137 hasConceptScore W3008825137C150194340 @default.
- W3008825137 hasConceptScore W3008825137C165864922 @default.
- W3008825137 hasConceptScore W3008825137C16930146 @default.
- W3008825137 hasConceptScore W3008825137C198826908 @default.
- W3008825137 hasConceptScore W3008825137C28328180 @default.
- W3008825137 hasConceptScore W3008825137C502942594 @default.